CCND1 G870A polymorphism is associated with toxicity of methotrexate in childhood acute lymphoblastic leukemia
about
Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia.Clinical significance and prospective molecular mechanism of MALAT1 in pancreatic cancer exploration: a comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases.
P2860
CCND1 G870A polymorphism is associated with toxicity of methotrexate in childhood acute lymphoblastic leukemia
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
CCND1 G870A polymorphism is as ...... d acute lymphoblastic leukemia
@ast
CCND1 G870A polymorphism is as ...... d acute lymphoblastic leukemia
@en
type
label
CCND1 G870A polymorphism is as ...... d acute lymphoblastic leukemia
@ast
CCND1 G870A polymorphism is as ...... d acute lymphoblastic leukemia
@en
prefLabel
CCND1 G870A polymorphism is as ...... d acute lymphoblastic leukemia
@ast
CCND1 G870A polymorphism is as ...... d acute lymphoblastic leukemia
@en
P2093
P2860
P1476
CCND1 G870A polymorphism is as ...... d acute lymphoblastic leukemia
@en
P2093
Liucheng Rong
Meilin Wang
Yongjun Fang
Zhengdong Zhang
P2860
P304
11594-11600
P577
2015-09-01T00:00:00Z